{"id":"W1496015604","doi":"10.1016/s1387-2656(05)11012-6","title":"A Prospective, non-randomised phase 1–2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma","year":2005,"lang":"en","type":"article","venue":"Biotechnology annual review","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Amgen (Canada); Interior Health; Hôpital Maisonneuve-Rosemont; St. Michael's Hospital; Hamilton Health Sciences; Royal Victoria Hospital; University of Toronto; University Health Network; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Filgrastim; Regimen; Etoposide; Internal medicine; Gastroenterology; Leukocytopenia; Chemotherapy; Vincristine; Surgery; Neutropenia; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004837025,0.0003154544,0.001333314,0.0001833417,0.00008438368,0.000004510002,0.0001994,0.0006068358,0.0002402561],"category_scores_gemma":[0.0004813983,0.0002337011,0.0003437772,0.0006418135,0.0002811351,0.00009203688,0.00003584313,0.0002458123,0.00005136559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000155998,"about_ca_system_score_gemma":0.0005010027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001428184,"about_ca_topic_score_gemma":0.00001065545,"domain_scores_codex":[0.9980612,0.00003351504,0.000755579,0.0004769228,0.0002299763,0.0004428262],"domain_scores_gemma":[0.9986179,0.00006985322,0.0004898948,0.0004532425,0.0002588538,0.0001101828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2985126,0.005377146,0.0002335988,0.004471865,0.001798967,0.00007851866,0.0004198212,0.000005208139,0.002266326,0.0007387658,0.1041376,0.5819595],"study_design_scores_gemma":[0.7747337,0.01514943,0.0001424727,0.002886006,0.001665945,0.00007628387,0.0001874297,0.0001510506,0.00627406,0.0001096984,0.1981785,0.0004454444],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.560056,0.1910732,0.01405391,0.1141941,0.001484182,0.08932582,0.00259856,0.002173055,0.02504122],"genre_scores_gemma":[0.9445323,0.04470769,0.003905305,0.002164012,0.000167982,0.001818019,0.0003009725,0.0001035416,0.00230019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5815141,"threshold_uncertainty_score":0.9530054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007921199552399005,"score_gpt":0.2994663680224409,"score_spread":0.2915451684700419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}